PT1173177E - Utilizacao de compostos macrolidos para tratamento do olho seco - Google Patents

Utilizacao de compostos macrolidos para tratamento do olho seco

Info

Publication number
PT1173177E
PT1173177E PT00921047T PT00921047T PT1173177E PT 1173177 E PT1173177 E PT 1173177E PT 00921047 T PT00921047 T PT 00921047T PT 00921047 T PT00921047 T PT 00921047T PT 1173177 E PT1173177 E PT 1173177E
Authority
PT
Portugal
Prior art keywords
utilization
dry eye
eye treatment
macrolid
compounds
Prior art date
Application number
PT00921047T
Other languages
English (en)
Inventor
Ryuji Ueno
Original Assignee
Sucampo A G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22452015&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1173177(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sucampo A G filed Critical Sucampo A G
Publication of PT1173177E publication Critical patent/PT1173177E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
PT00921047T 1999-04-30 2000-04-26 Utilizacao de compostos macrolidos para tratamento do olho seco PT1173177E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13200999P 1999-04-30 1999-04-30

Publications (1)

Publication Number Publication Date
PT1173177E true PT1173177E (pt) 2005-03-31

Family

ID=22452015

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00921047T PT1173177E (pt) 1999-04-30 2000-04-26 Utilizacao de compostos macrolidos para tratamento do olho seco

Country Status (23)

Country Link
EP (1) EP1173177B2 (pt)
JP (2) JP5036934B2 (pt)
KR (1) KR20020015316A (pt)
CN (1) CN1190194C (pt)
AR (1) AR023807A1 (pt)
AT (1) ATE281167T1 (pt)
AU (1) AU777915B2 (pt)
BR (1) BR0011225A (pt)
CA (1) CA2372448A1 (pt)
CZ (1) CZ20013769A3 (pt)
DE (1) DE60015516T2 (pt)
ES (1) ES2232439T3 (pt)
HK (2) HK1043321B (pt)
HU (1) HUP0200864A3 (pt)
IL (1) IL146162A0 (pt)
MX (1) MXPA01010988A (pt)
NO (1) NO20015288L (pt)
NZ (1) NZ515339A (pt)
PT (1) PT1173177E (pt)
TR (1) TR200103119T2 (pt)
TW (1) TWI230066B (pt)
WO (1) WO2000066122A1 (pt)
ZA (1) ZA200108905B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0011225A (pt) * 1999-04-30 2002-03-19 Sucampo Ag Agente para tratar de olhos secos, seu método e uso
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
WO2003004098A1 (en) 2001-07-06 2003-01-16 Sucampo Ag Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent
AR038628A1 (es) * 2002-03-04 2005-01-19 Novartis Ag Composicion oftalmica
JP2005536531A (ja) * 2002-08-09 2005-12-02 スキャンポ ファーマシューティカルズ、インコーポレイテッド アレルギー性疾患を処置する為のｆｋ５０６誘導体を含む医薬組成物及びその使用
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
AR042890A1 (es) * 2003-01-16 2005-07-06 Sucampo Pharmaceuticals Inc Metodo de tratamiento del ojo seco con una composicion oftalmica que contiene un compuesto macrolido
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
US7083802B2 (en) * 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
EP1674091B1 (en) 2003-10-06 2014-04-23 Ophtecs Corporation Ophthalmic composition for treating lacrimal disorders
DK1848431T3 (en) 2005-02-09 2016-04-18 Santen Pharmaceutical Co Ltd LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS
EP1904056B1 (en) 2005-07-18 2009-04-29 Minu, L.L.C. Use of a macrolide to restore corneal sensation
JP5528708B2 (ja) 2006-02-09 2014-06-25 参天製薬株式会社 安定な製剤ならびにそれらを調製および使用する方法
CN103127100A (zh) 2006-03-23 2013-06-05 参天制药株式会社 用于与血管通透性有关的疾病或病症的制剂和方法
EP2335735A1 (en) * 2009-12-14 2011-06-22 Novaliq GmbH Pharmaceutical composition for treatment of dry eye syndrome
CN111278401B (zh) * 2017-05-30 2023-08-15 艾克思摩尔有限公司 递送抗生素大环内酯治疗干眼综合征的组合物和方法
EP3691654A4 (en) 2017-09-25 2021-11-24 Surface Pharmaceuticals, Inc. OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF EYE SURFACE DISEASES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0406791B1 (en) * 1989-07-05 1995-02-01 Fujisawa Pharmaceutical Co., Ltd. Aqueous liquid composition for external use
JP3158437B2 (ja) * 1991-04-26 2001-04-23 藤沢薬品工業株式会社 眼疾患に対するマクロライド化合物の使用
ZA924953B (en) * 1991-07-25 1993-04-28 Univ Louisville Res Found Method of treating ocular inflammation
AR004480A1 (es) * 1995-04-06 1998-12-16 Amico Derin C D Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen
GB9601120D0 (en) * 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
EP1067926A2 (en) * 1998-04-06 2001-01-17 Fujisawa Pharmaceutical Co., Ltd. Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins
ES2284248T3 (es) * 1998-04-27 2007-11-01 Astellas Pharma Inc. Formulacion farmaceutica en gel que comprende un compuesto triciclico (fk-506/tacrolimus).
US6376517B1 (en) * 1998-08-14 2002-04-23 Gpi Nil Holdings, Inc. Pipecolic acid derivatives for vision and memory disorders
BR0011225A (pt) * 1999-04-30 2002-03-19 Sucampo Ag Agente para tratar de olhos secos, seu método e uso

Also Published As

Publication number Publication date
NO20015288D0 (no) 2001-10-29
TWI230066B (en) 2005-04-01
ES2232439T3 (es) 2005-06-01
AU777915B2 (en) 2004-11-04
NZ515339A (en) 2004-02-27
IL146162A0 (en) 2002-07-25
NO20015288L (no) 2001-10-29
BR0011225A (pt) 2002-03-19
TR200103119T2 (tr) 2002-04-22
ZA200108905B (en) 2002-12-24
EP1173177B2 (en) 2014-03-05
JP2002543132A (ja) 2002-12-17
JP2012116857A (ja) 2012-06-21
HK1043321B (zh) 2005-07-15
EP1173177A1 (en) 2002-01-23
AR023807A1 (es) 2002-09-04
HUP0200864A2 (hu) 2002-07-29
CA2372448A1 (en) 2000-11-09
DE60015516D1 (de) 2004-12-09
HK1046099A1 (zh) 2002-12-27
EP1173177B1 (en) 2004-11-03
CN1353608A (zh) 2002-06-12
WO2000066122A1 (en) 2000-11-09
MXPA01010988A (es) 2004-04-21
HUP0200864A3 (en) 2004-07-28
CZ20013769A3 (cs) 2002-03-13
ATE281167T1 (de) 2004-11-15
CN1190194C (zh) 2005-02-23
HK1043321A1 (en) 2002-09-13
DE60015516T2 (de) 2005-12-01
JP5036934B2 (ja) 2012-09-26
KR20020015316A (ko) 2002-02-27
AU4142900A (en) 2000-11-17

Similar Documents

Publication Publication Date Title
PT1173177E (pt) Utilizacao de compostos macrolidos para tratamento do olho seco
EE200200172A (et) Ühendid isheemia ravimiseks
IS6185A (is) Ný notkun á efnasamböndum sem bakteríueyðandi efni
DE60011570D1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
DE60020976D1 (de) Farbstoff-polarisator
NO20001870D0 (no) Ny fremgangsmõte for behandling
PT1292591E (pt) Derivados biciclicos substituidos para o tratamento de crescimento de celula anormal
ATE368765T1 (de) Wäschebehandlung
PT1206436E (pt) Retinoides para o tratamento de enfisema
PT1228032E (pt) Composicoes contendo derivados do acido hidroxieicosatetraenoico e metodos de utilizacao para o tratamento de desordens do olho seco
DE69918171D1 (de) Wäschebehandlung
ES1047622Y (es) Aplicador de vendaje
ES1044448Y (es) Auto-aplicador de vendaje
NO20005027L (no) Fremgangsmåte for våt-granulering
FI991220A0 (fi) Menetelmä massan käsittelemiseksi
ATE314040T1 (de) Tamponapplikator
ID29966A (id) Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi
PT1220858E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes virais
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
ITPI990068A0 (it) Bottale per le lavorazioni a secco delle pelli
ATE290060T1 (de) Wäschebehandlung
PT1175417E (pt) Compostos substituidos de benzolactamas
PT1157987E (pt) S-nitrosotiois como agentes para o tratamento de disfuncoes circulatorias
FI990127A0 (fi) Menetelmä massan käsittelemiseksi
IT1315833B1 (it) Tamburo di trattamento per la sbavatura di pezzi stampati.